This gives you concrete evidence to take to your GP or a private clinician, ensuring you can have a productive conversation and get the right treatment without any needless delays
Plaintiffs claim that Novo Nordisk failed to properly warn patients and healthcare providers about these dangers, while promoting Saxenda as a safe means of weight loss
These videos highlight personal experiences, individual journeys, and what its like to go through a fully online program with medical oversight
The route prescribed
To date, dulaglutide, semaglutide, and tirzepatide have been the three predominant GLP-1 therapeutics employed in the treatment of T2DM, and their applications have been broadened to include weight management
Sources Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial (2024) Journal of the American Medical Association [Accessed 2 December 2025] Dosing Schedule | Ozempic (semaglutide) (2025) [Accessed 2 December 2025] GIP and GLP1, the two incretin hormones: Similarities and differences (2010) Journal of Diabetes Investigation [Accessed 2 December 2025] Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021) New England Journal of Medicine [Accessed 2 December 2025]